약물감시 인공지능(AI) 시장 보고서(2026년)

Artificial intelligence (AI) in pharmacovigilance refers to the use of machine learning, natural language processing, and advanced analytical technologies to identify, evaluate, monitor, and prevent adverse drug reactions and other medication safety concerns. It improves the efficiency and precision of drug safety monitoring by automating the analysis of large volumes of structured and unstructured healthcare information, enabling faster signal identification, risk evaluation, and regulatory reporting. It supports more effective decision-making in drug safety management by minimizing manual effort and enhancing the reliability of safety-related insights.

The primary components of artificial intelligence (AI) in pharmacovigilance include software and services. Software refers to AI-enabled platforms that automate the detection, assessment, monitoring, and reporting of adverse drug reactions and safety signals throughout a product's lifecycle. These solutions utilize technologies including machine learning, natural language processing, predictive analytics, robotic process automation, and generative artificial intelligence or large language models and are deployed through cloud-based and on-premises models. They are applied in adverse event detection, signal detection, data integration and management, drug safety monitoring, and automated report generation, serving end users including pharmaceutical companies, biotechnology companies, contract research organizations, regulatory agencies, hospitals and healthcare providers, and academic and research institutes.

Tariffs are influencing the artificial intelligence (AI) in pharmacovigilance market by increasing the cost of imported advanced computing infrastructure, cloud-based processing systems, and specialized software platforms required for drug safety monitoring and analytics. This is affecting deployment across pharmaceutical companies, biotechnology firms, contract research organizations, and regulatory agencies, particularly in regions dependent on global technology imports such as Asia-Pacific and Latin America. Software-intensive segments such as machine learning models and natural language processing-based safety systems are also affected due to their reliance on cross-border digital infrastructure. However, tariffs are also encouraging localization of data centers, regional development of pharmacovigilance software solutions, and investment in domestic regulatory technology ecosystems, improving long-term resilience and data sovereignty.

The artificial intelligence (AI) in pharmacovigilance market size has grown rapidly in recent years. It will grow from $0.77 billion in 2025 to $0.92 billion in 2026 at a compound annual growth rate (CAGR) of 19.3%. The growth in the historic period can be attributed to rise in global adverse drug reaction reporting requirements, expansion of pharmacovigilance regulatory frameworks, increasing adoption of electronic health records, growth in clinical trial data complexity, early use of rule based drug safety monitoring systems.

The artificial intelligence (AI) in pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $1.88 billion in 2030 at a compound annual growth rate (CAGR) of 19.6%. The growth in the forecast period can be attributed to rapid adoption of ai powered drug safety surveillance systems, increasing volume of real world healthcare data for analysis, expansion of regulatory compliance requirements for drug safety, growing use of predictive analytics in adverse event detection, rising integration of multi source clinical data for pharmacovigilance. Major trends in the forecast period include rise of automated literature screening for adverse drug reaction identification, increasing adoption of real world evidence analytics in drug safety monitoring, growing use of generative AI for regulatory pharmacovigilance reporting, expansion of automated case intake and workflow processing systems, surge in cross-border regulatory harmonization for drug safety data exchange.

The increasing volume of adverse event (AE) reports is expected to propel the growth of the artificial intelligence (AI) in pharmacovigilance market going forward. Adverse event (AE) reports refer to documented cases of unintended and harmful reactions or outcomes experienced after the use of a medical product or drug. The volume of adverse event (AE) reports is increasing due to stricter regulatory requirements that require healthcare providers and pharmaceutical companies to report a broader range of safety issues more frequently and in greater detail. Artificial intelligence (AI) in pharmacovigilance processes adverse event (AE) reports by automatically collecting and analyzing large volumes of safety data from multiple sources in real time, enabling faster detection of drug safety signals while improving the accuracy, consistency, and regulatory compliance of reporting. For instance, in February 2024, according to the Analysis of Adverse Drug Reactions 2023 Report by the Department of Health Abu Dhabi, a UAE-based regulatory body, a total of 1,522 adverse drug reaction reports were submitted to the pharmacovigilance program between January and December 2023, representing a 235% increase compared to the average annual number of reports recorded in previous years. Therefore, the increasing volume of adverse event (AE) reports is driving the growth of the artificial intelligence (AI) in pharmacovigilance market.

Key companies operating in the artificial intelligence (AI) in pharmacovigilance market are focusing on developing innovative treatments, such as agentic AI-driven pharmacovigilance platforms, to enhance automated adverse event detection, regulatory compliance, and efficiency in drug safety monitoring by reducing manual case-processing workloads and improving signal detection accuracy. Agentic AI pharmacovigilance platforms are advanced software systems that use domain-trained machine learning models, natural language processing, and workflow orchestration to independently perform and coordinate safety tasks such as case intake, literature surveillance, signal detection, and aggregate reporting. For example, in May 2026, RxLogix Systems Inc., a US-based pharmacovigilance technology provider, launched an upgraded PVOne.AI platform, an innovative AI-enabled pharmacovigilance system that integrates agentic AI capabilities to automate and orchestrate end-to-end drug safety workflows. The platform is designed to operate across case intake, adverse event monitoring, literature surveillance, signal detection, aggregate reporting, and risk management, using contextual reasoning and domain-trained models to support regulatory-grade decision-making. It introduces human-in-the-loop controls to ensure compliance with FDA and global pharmacovigilance standards while significantly reducing manual effort in case processing by up to 80% and improving reviewer productivity by up to 75%. The system also aims to enable up to 50% touchless workflows by minimizing repetitive processing tasks and enhancing prioritization of safety signals in large-scale pharmaceutical datasets.

In January 2023, Certara Inc., a US-based healthcare technology and biosimulation company, acquired Vyasa LLC for an undisclosed amount. Through this acquisition, Certara Inc. aimed to strengthen its end-to-end drug development and biosimulation platform by integrating Vyasa's deep learning and artificial intelligence capabilities, thereby enhancing its ability to analyze structured and unstructured biomedical data, accelerate predictive modeling, and improve decision-making across drug discovery and development workflows. Vyasa LLC is a US-based company that provides AI software and services relevant to pharmacovigilance and drug development through its AI-powered data analytics platform used in life sciences workflows.

Major companies operating in the artificial intelligence (AI) in pharmacovigilance market are Oracle Corporation; Microsoft Corporation; Google LLC; Accenture plc; NVIDIA Corporation; IQVIA Holdings Inc.; ArisGlobal; Veeva Systems Inc.; Cognizant Technology Solutions Corporation; Tata Consultancy Services Limited; Infosys Limited; Wipro Limited; SAS Institute Inc.; Genpact Limited; Snowflake Inc.; ICON Public Limited Company; Open Text Corporation; Certara Inc.; ExlService Holdings Inc.; Ennov Group; EXTEDO; Biologit; Anju Software; Bronze Oak

North America was the largest region in the artificial intelligence (AI) in pharmacovigilance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in pharmacovigilance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) in pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) in pharmacovigilance market includes revenues earned by entities by providing services such as drug safety data mining and analytics, case processing and narrative generation, regulatory compliance and reporting solutions, predictive risk modeling, and integration of pharmacovigilance systems with healthcare databases. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The artificial intelligence (AI) in pharmacovigilance market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in pharmacovigilance market statistics, including artificial intelligence (AI) in pharmacovigilance industry global market size, regional shares, competitors with a artificial intelligence (AI) in pharmacovigilance market share, detailed artificial intelligence (AI) in pharmacovigilance market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in pharmacovigilance industry. This artificial intelligence (AI) in pharmacovigilance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial Intelligence (AI) In Pharmacovigilance Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai) in pharmacovigilance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in pharmacovigilance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) in pharmacovigilance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Software; Services
• 2) By Technology: Machine Learning; Natural Language Processing; Predictive Analytics; Robotic Process Automation; Generative Artificial Intelligence Or Large Language Models
• 3) By Deployment Mode: Cloud-Based; On-Premises
• 4) By Application: Adverse Event Detection; Signal Detection; Data Integration And Management; Drug Safety Monitoring; Automated Report Generation
• 5) By End User: Pharmaceutical Companies; Biotechnology Companies; Contract Research Organizations; Regulatory Agencies; Hospitals And Healthcare Providers; Academic And Research Institutes
• Subsegments:
• 1) By Software: Case Processing And Workflow Automation Software; Predictive Analytics And Risk Assessment Tools; Natural Language Processing Based Pharmacovigilance Software; Artificial Intelligence Based Literature Screening Software; Regulatory Compliance Management Software; Real World Evidence Analytics Platforms; Clinical Data Mining Software
• 2) By Services: Pharmacovigilance Consulting Services; Artificial Intelligence Model Training And Validation Services; Regulatory Reporting Services; Medical Review And Case Assessment Services; Literature Monitoring Services; Pharmacovigilance Outsourcing Services; Safety Data Analytics Services
• Companies Mentioned: Oracle Corporation; Microsoft Corporation; Google LLC; Accenture plc; NVIDIA Corporation; IQVIA Holdings Inc.; ArisGlobal; Veeva Systems Inc.; Cognizant Technology Solutions Corporation; Tata Consultancy Services Limited; Infosys Limited; Wipro Limited; SAS Institute Inc.; Genpact Limited; Snowflake Inc.; ICON Public Limited Company; Open Text Corporation; Certara Inc.; ExlService Holdings Inc.; Ennov Group; EXTEDO; Biologit; Anju Software; Bronze Oak
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI) In Pharmacovigilance Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Artificial Intelligence (AI) In Pharmacovigilance Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI) In Pharmacovigilance Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI) In Pharmacovigilance Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Biotechnology, Genomics & Precision Medicine
  • 4.1.4 Fintech, Blockchain, Regtech & Digital Finance
  • 4.1.5 Internet Of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rise Of Automated Literature Screening For Adverse Drug Reaction Identification
  • 4.2.2 Increasing Adoption Of Real World Evidence Analytics In Drug Safety Monitoring
  • 4.2.3 Growing Use Of Generative Ai For Regulatory Pharmacovigilance Reporting
  • 4.2.4 Expansion Of Automated Case Intake And Workflow Processing Systems
  • 4.2.5 Surge In Cross-Border Regulatory Harmonization For Drug Safety Data Exchange

5. Artificial Intelligence (AI) In Pharmacovigilance Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Companies
• 5.3 Contract Research Organizations
• 5.4 Regulatory Agencies
• 5.5 Hospitals And Healthcare Providers

6. Artificial Intelligence (AI) In Pharmacovigilance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI) In Pharmacovigilance Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Artificial Intelligence (AI) In Pharmacovigilance PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Artificial Intelligence (AI) In Pharmacovigilance Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Artificial Intelligence (AI) In Pharmacovigilance Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Artificial Intelligence (AI) In Pharmacovigilance Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI) In Pharmacovigilance Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI) In Pharmacovigilance Market Segmentation

• 9.1. Global Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Software, Services
• 9.2. Global Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Machine Learning, Natural Language Processing, Predictive Analytics, Robotic Process Automation, Generative Artificial Intelligence Or Large Language Models
• 9.3. Global Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cloud-Based, On-Premises
• 9.4. Global Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Adverse Event Detection, Signal Detection, Data Integration And Management, Drug Safety Monitoring, Automated Report Generation
• 9.5. Global Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Regulatory Agencies, Hospitals And Healthcare Providers, Academic And Research Institutes
• 9.6. Global Artificial Intelligence (AI) In Pharmacovigilance Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Case Processing And Workflow Automation Software, Predictive Analytics And Risk Assessment Tools, Natural Language Processing Based Pharmacovigilance Software, Artificial Intelligence Based Literature Screening Software, Regulatory Compliance Management Software, Real World Evidence Analytics Platforms, Clinical Data Mining Software
• 9.7. Global Artificial Intelligence (AI) In Pharmacovigilance Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmacovigilance Consulting Services, Artificial Intelligence Model Training And Validation Services, Regulatory Reporting Services, Medical Review And Case Assessment Services, Literature Monitoring Services, Pharmacovigilance Outsourcing Services, Safety Data Analytics Services

10. Artificial Intelligence (AI) In Pharmacovigilance Market Regional And Country Analysis

• 10.1. Global Artificial Intelligence (AI) In Pharmacovigilance Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Artificial Intelligence (AI) In Pharmacovigilance Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI) In Pharmacovigilance Market

• 11.1. Asia-Pacific Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI) In Pharmacovigilance Market

• 12.1. China Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI) In Pharmacovigilance Market

• 13.1. India Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI) In Pharmacovigilance Market

• 14.1. Japan Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI) In Pharmacovigilance Market

• 15.1. Australia Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI) In Pharmacovigilance Market

• 16.1. Indonesia Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI) In Pharmacovigilance Market

• 17.1. South Korea Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI) In Pharmacovigilance Market

• 18.1. Taiwan Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI) In Pharmacovigilance Market

• 19.1. South East Asia Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI) In Pharmacovigilance Market

• 20.1. Western Europe Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI) In Pharmacovigilance Market

• 21.1. UK Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI) In Pharmacovigilance Market

• 22.1. Germany Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI) In Pharmacovigilance Market

• 23.1. France Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI) In Pharmacovigilance Market

• 24.1. Italy Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI) In Pharmacovigilance Market

• 25.1. Spain Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI) In Pharmacovigilance Market

• 26.1. Eastern Europe Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI) In Pharmacovigilance Market

• 27.1. Russia Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI) In Pharmacovigilance Market

• 28.1. North America Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI) In Pharmacovigilance Market

• 29.1. USA Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI) In Pharmacovigilance Market

• 30.1. Canada Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI) In Pharmacovigilance Market

• 31.1. South America Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI) In Pharmacovigilance Market

• 32.1. Brazil Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI) In Pharmacovigilance Market

• 33.1. Middle East Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI) In Pharmacovigilance Market

• 34.1. Africa Artificial Intelligence (AI) In Pharmacovigilance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Artificial Intelligence (AI) In Pharmacovigilance Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI) In Pharmacovigilance Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI) In Pharmacovigilance Market Competitive Landscape And Company Profiles

• 36.1. Artificial Intelligence (AI) In Pharmacovigilance Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Artificial Intelligence (AI) In Pharmacovigilance Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Artificial Intelligence (AI) In Pharmacovigilance Market Company Profiles
  • 36.3.1. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Google LLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Accenture plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI) In Pharmacovigilance Market Other Major And Innovative Companies

• IQVIA Holdings Inc., ArisGlobal, Veeva Systems Inc., Cognizant Technology Solutions Corporation, Tata Consultancy Services Limited, Infosys Limited, Wipro Limited, SAS Institute Inc., Genpact Limited, Snowflake Inc., ICON Public Limited Company, Open Text Corporation, Certara Inc., ExlService Holdings Inc., Ennov Group

38. Global Artificial Intelligence (AI) In Pharmacovigilance Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Pharmacovigilance Market

41. Artificial Intelligence (AI) In Pharmacovigilance Market High Potential Countries, Segments and Strategies

• 41.1 Artificial Intelligence (AI) In Pharmacovigilance Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Artificial Intelligence (AI) In Pharmacovigilance Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Artificial Intelligence (AI) In Pharmacovigilance Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer